Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
23841
CAS Number:
951623-88-4
5-Fluoro-1-((4-(Phénylsulfonyl)Pipérazine-1-Yl)Méthyl)-1,2,3,4-Tétrahydroisoquinoléine
Documents
$309.66 /100 mg
Taille
Request Bulk Quote
Product Information

5-Fluoro-1-((4-(Phenylsulfonyl)Piperazin-1-Yl)Methyl)-1,2,3,4-Tetrahydroisoquinoline is a versatile compound with significant potential in pharmaceutical research and development. This compound features a unique structure that combines a tetrahydroisoquinoline core with a piperazine moiety, making it an attractive candidate for the synthesis of novel therapeutic agents. Its fluorine substitution enhances biological activity, which is particularly beneficial in drug design, especially for targeting specific receptors or enzymes in various diseases.

Researchers have explored its applications in developing treatments for neurological disorders and other conditions where piperazine derivatives have shown promise. The sulfonyl group contributes to its solubility and bioavailability, making it easier to formulate into effective drug delivery systems. With its unique properties, this compound stands out in the field of medicinal chemistry, offering researchers a valuable tool for advancing therapeutic innovations.

CAS Number
951623-88-4
Molecular Formula
C20H24FN3O2S
Molecular Weight
389.49
MDL Number
MFCD09788585
PubChem ID
45925936
Conditions
Conserver à 0-8°C
General Information
CAS Number
951623-88-4
Molecular Formula
C20H24FN3O2S
Molecular Weight
389.49
MDL Number
MFCD09788585
PubChem ID
45925936
Conditions
Conserver à 0-8°C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

5-Fluoro-1-((4-(Phenylsulfonyl)Piperazin-1-Yl)Methyl)-1,2,3,4-Tetrahydroisoquinoline is widely utilized in research focused on:

  • Pharmaceutical Development: This compound is being explored for its potential as an antidepressant and anxiolytic agent, providing researchers with a new avenue for treating mood disorders.
  • Cancer Research: Its unique structure may inhibit certain cancer cell lines, making it a candidate for further studies in oncology, potentially leading to innovative therapies.
  • Neuropharmacology: The compound's interaction with neurotransmitter systems can help in understanding neurological disorders, offering insights into drug design for conditions like schizophrenia.
  • Drug Delivery Systems: The chemical's properties can be leveraged in creating targeted drug delivery mechanisms, enhancing the efficacy of treatments while minimizing side effects.
  • Biochemical Assays: It can serve as a valuable tool in biochemical assays to study enzyme interactions and receptor binding, facilitating advancements in drug discovery processes.

Citations